Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Outcome of Continuous Renal Replacement Therapy in Children

소아에서 지속적 신대체요법의 치료 결과

  • LIm, Yeon Jung (Department of Pediatrics, University of Ulsan, College of Medicine, Asan Medical Center) ;
  • Jin, Hyun-seung (Department of Pediatrics, University of Ulsan, College of Medicine, Asan Medical Center) ;
  • Hahn, Hyewon (Department of Pediatrics, University of Ulsan, College of Medicine, Asan Medical Center) ;
  • Oh, Sei Ho (Department of Pediatrics*, Handong University, Sunlin Hospital) ;
  • Park, Seong Jong (Department of Pediatrics, University of Ulsan, College of Medicine, Asan Medical Center) ;
  • Park, Young Seo (Department of Pediatrics, University of Ulsan, College of Medicine, Asan Medical Center)
  • 임연정 (울산대학교 의과대학 서울아산병원 소아과) ;
  • 진현승 (울산대학교 의과대학 서울아산병원 소아과) ;
  • 한혜원 (울산대학교 의과대학 서울아산병원 소아과) ;
  • 오세호 (한동대학교 선린병원 소아과) ;
  • 박성종 (울산대학교 의과대학 서울아산병원 소아과) ;
  • 박영서 (울산대학교 의과대학 서울아산병원 소아과)
  • Received : 2004.08.13
  • Accepted : 2004.09.22
  • Published : 2005.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : There is growing use of continuous renal replacement therapy(CRRT) for pediatric patients, but reports about the use and outcome of CRRT in children is rare in Korea. We report our experiences of CRRT in critically ill pediatric patients. Methods : We reviewed the medical records of 23 pediatric patients who underwent CRRT at Asan Medical Center between May 2001 and May 2004. We evaluated underlying diseases, clinical features, treatment courses, CRRT modalities and outcomes. Results : Ages ranged from three days to 16 years with a median of five years. Patients weighed 2.4 to 63.9 kg(median 23.0 kg; 10 patients ${\leq}20kg$). The underlying diseases were malignancy(nine cases), multiple organ dysfunction syndrome(five cases), hyperammonemia(four cases), acute renal failure associated with liver failure(three cases), dilated cardiomyopathy(one case) and congenital nephrotic syndrome(one case). Pediatric Risk of Mortality(PRISM) III score was $17.6{\pm}7.6$ and the mean number of failing organs was $3.0{\pm}1.7$. Duration of CRRT was one to 27 days(median : nine days). Eleven patients(47.8%) survived. Chronic renal failure developed in two cases, intracranial hemorrhage in one case, and chylothorax in one case among the survivors. PRISM III score and the number of vasopressor before the start of CRRT was significantly lower in the survivors($12.7{\pm}4.2$ and $0.9{\pm}1.1$) compared with nonsurvivors($22.1{\pm}7.8$ and $2.4{\pm}1.4$)(P<0.05). Conclusion : CRRT driven in venovenous mode is an effective and safe method of renal support for critically-ill infants and children to control fluid balance and metabolic derangement. Survival is affected by PRISM III score and the number of vasopressors at the initiation of CRRT.

목 적 : 혈역동 상태가 불안정한 신부전 환자에서 CRRT 시행이 증가하고 있으나 국내에서는 소아 환자에서의 보고는 드물다. 그러므로 저자들은 소아 환자들에서 CRRT의 치료 경험을 보고하고자 한다. 방 법 : 2001년 5월부터 2004년 5월까지 서울아산병원에서 CRRT를 시행한 소아 환아 23례를 대상으로 하여 원인 질환 및 신대체요법 시작 시 임상 양상과 경과, CRRT의 방법과 결과를 검토하였고 생존군과 사망군 사이의 차이를 비교 분석하였다. 결 과 : 23명의 환아 중 남아가 12명, 여아가 11명이었고 연령은 3일에서 16세(중간값 5세)였다. 체중은 2.4 kg에서 63.9 kg(중간값 23.0 kg)였고 20 kg 이하가 5명이었다. 대상 환아의 기저 질환은 종양성 질환이 9명, 다장기 부전 증후군 5명, 선천성 대사이상 질환에 의한 고암모니아 혈증 4명, 간기능 부전과 동반된 급성 신부전 3명, 확장성 심근증 1명, 선천성 신증후군 1명 이었다. PRISM III 점수는 $17.6{\pm}7.6$이었고 평균 부전 장기의 수는 $3.0{\pm}1.7$개였다. CRRT를 시행한 기간은 1일에서 27일(평균 9일)이었다. 23명의 환아 중 11명(47.8%)이 생존하였다. 이중 4명에서 후유증이 남았는데 1명은 뇌출혈이 발견되었고 2명은 만성 신부전으로 진행하였으며 또 다른 1명에서는 내경정맥에 2중 도관 삽입과 관련된 상대정맥 혈전으로 인해 유미흉이 발생하였다. 생존군과 사망군을 비교하였을 때 생존군에서 CRRT 시작 당시의 PRISM III 점수와 투여되는 승압제의 수가 유의하게 낮았다(P<0.05). 결 론 : 혈역동상태가 불안정하고 다장기 부전이 동반된 급성 신부전 환아에서 CRRT를 효과적으로 시행할 수 있었고 생존율에는 CRRT 시작 전 PRISM III 점수, 승압제 투여 정도가 중요한 요인이었다.

Keywords

References

  1. Andreoli SP. Acute renal failure. Curr Opin Pediatr 2002;14:183-188 https://doi.org/10.1097/00008480-200204000-00007
  2. Goldstein SL. Overview of pediatric renal replacement therapy in acute renal failure. Artif Organs 2003;27:781-5 https://doi.org/10.1046/j.1525-1594.2003.07281.x
  3. Flynn JT. Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol 2002;17:61-9 https://doi.org/10.1007/s004670200011
  4. Lowrie LH. Renal replacement therapies in pediatric multiorgan dysfunction syndrome. Pediatr Nephrol 2000;14:6-12 https://doi.org/10.1007/s004670050002
  5. Maxvold NJ, Smoyer WE, Gardner JJ, Bunchman TE. Management of acute renal failure in the pediatric patient : hemofiltration versus hemodialysis. Am J Kidney Dis 1997;30(4 Suppl):84S-88S https://doi.org/10.1016/S0272-6386(97)90547-3
  6. Health and Public Policy Committee, American College of Physicians. Clinical competence in acute peritoneal dialysis. Ann Intern Med 1988;108:763-5 https://doi.org/10.7326/0003-4819-108-5-763
  7. Fleming F, Bohn D, Edwards H, Cox P, Geary D, Mc- Crindle BW, et al. Renal replacement therapy after repair of congenital heart disease in children : a comparison of hemofiltration and peritoneal dialysis. J Thoracic Cardiovasc Surg 1995;109:322-31. https://doi.org/10.1016/S0022-5223(95)70394-2
  8. Park SB. Continuous renal replacement therapy. Korean J Nephrol 1999;18 Suppl 1:44-54.
  9. Warady BA, Bunchman T. Dialysis therapy for children with acute renal failure : survey results. Pediatr Nephrol 2000;15:11-3 https://doi.org/10.1007/s004670000420
  10. Lim YJ, Hahn H, Lee BS, Park YS. The experiences of pump-driven continuous venovenous hemofiltration therapy in pediatric patients. J Korean Soc Pediatr Nephrol 2002;6:251-8
  11. Jang WK, Hahn H, Shin YR, Park HK, Kim AE, Park YS, et al. A case of continuous venovenous hemodiafiltration in the treatment of neonatal hyperammonemia due to methylmalonic acidemia. J Korean Soc Pediatr Nephrol 2003;7:96-102
  12. Pollack MM, Patel KM, Ruttimann UE. PRISM III : an updated pediatric risk of mortality score. Crit Care Med 1996; 24:743-52 https://doi.org/10.1097/00003246-199605000-00004
  13. Storck M, Hartl WH, Zimmerer E, Inthorn D. Comparison of pump-driven and spontaneous continuous hemofiltraion in postoperative acute renal failure. Lancet 1991;337:452-5 https://doi.org/10.1016/0140-6736(91)93393-N
  14. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M. Continuous hemofiltration/hemodiafiltration in critical care. Ther Apher 2002;6:193-8 https://doi.org/10.1046/j.1526-0968.2002.00431.x
  15. Symons JM, Brophy PD, Gregory MJ, McAfee N, Somers MJG, Bunchman TE, et al. Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 2003;41: 984-9 https://doi.org/10.1016/S0272-6386(03)00195-1
  16. Burchardi H. History and development of continuous renal replacement techniques. Kidney Int 1998;53 Suppl 66:120-4
  17. Zobel G, RIng E, Rodl S. Continuous renal replacement therapy in critically ill pediatric patients. Am J Kidney Dis 1996;28(3 Suppl):28S-34S https://doi.org/10.1016/S0272-6386(96)90077-3
  18. Bunchman TE, Maxvold NJ, Kershaw DB, Sedman AB, Custer JR. Continuous venovenous hemodiafiltraion in infants and children. Am J Kidney Dis 1995;25:17-21 https://doi.org/10.1016/0272-6386(95)90618-5
  19. Thomas MC, Harris DCH. Problems and advantages of continuous renal replacement therapy. Nephrology 2002;7: 110-4 https://doi.org/10.1046/j.1440-1797.2002.00103.x
  20. Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A. Continuous renal replacement therapies : anticoagulation in the critically ill at high risk of bleeding. J Nephrol 2003;16:566-71
  21. Swartz R, Pasko D, O'Toole J, Starmann B. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 2004;61:134-43
  22. Smoyer WE, McAdams C, Kaplan BS, Sherbotie JR. Determinants of survival in pediatric contiuous hemofiltration. J Am Soc Nephrol 1995;6:1401-9
  23. Ellis EN, Pearson D, Belsha CW, Berry PL. Use of pumpassisted hemofiltration in children with acute renal failure. Pediatr Nephrol 1997;11:196-200 https://doi.org/10.1007/s004670050259
  24. Bunchman TE, McBryde KD, Mottes TE, Gardner JJ, Maxvold NJ, Brophy PD. Pediatric acute renal failure : outcome by modality and disease. Pediatr Nephrol 2001;16: 1067-71 https://doi.org/10.1007/s004670100029
  25. Goldstein SL, Currier H, Graf JM, Cosio CC, Brewer ED, Sachdera R. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001;107:1309-12 https://doi.org/10.1542/peds.107.6.1309
  26. Michael M, Kuehnle I, Goldstein SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol 2004;19:91-5 https://doi.org/10.1007/s00467-003-1313-z
  27. Kang YS, Lee SY, Han SY, Jo SK, Shin JH, Cha DR, et al. The clinical characteristics of patients treated with continuous renal replacement therapy. Korean J Nephrol 2002;21:93-101
  28. van Bommel E, Bouvy ND, So KL, Ziestse R, Vincent HH, Bruining HA, et al. Acute dialytic support for the critically ill : intermittent hemodialysis versus continuous arteriovenous hemodiafiltraion. Am J Nephrol 1995;15:192-200 https://doi.org/10.1159/000168832
  29. Lugones F, Chiotti G, Carrier M, Parent D, Thibodeau J, Ducharme B, et al. Continuous renal replacement therapy after cardiac surgery. Blood Purif 2004;22:249-55 https://doi.org/10.1159/000078493